CIM
ACOR

Calvert Investment Management’s Acorda Therapeutics ACOR Stock Holding History

Calvert Investment Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,056
Closed -$4.34M – 366
2013
Q3 		$4.34M Hold
1,056
– – 0.54% 71
2013
Q2 		$4.18M Buy
+1,056
New +$4.35M 0.57% 62

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Calvert Investment Management's ACOR Position: Q4 2013 in Review

Calvert Investment Management sold out of Acorda Therapeutics (ACOR) in Q4 2013, closing a stake of 1,056 shares — an estimated $4.34M sold.

Calvert Investment Management first reported a position in ACOR in Q2 2013 and held it in 2 quarters. The position peaked at $4.34M in Q3 2013. 163 funds tracked by Wall St. Rank hold ACOR as of Q4 2013.

  • Calvert Investment Management reported no remaining Acorda Therapeutics position as of Q4 2013 after selling out during the quarter.
  • Calvert Investment Management sold 1,056 Acorda Therapeutics shares in Q4 2013, an estimated $4.34M.
  • Calvert Investment Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 2 quarters.
  • Calvert Investment Management's Acorda Therapeutics position peaked at $4.34M in Q3 2013.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2013.

Based on Calvert Investment Management's 13F filing for Q4 2013, filed 10 Jan 2014.